|
Botox in the treatment of headaches:
(Coming soon!)
Patients with transformed migraine have lower pain tolerance:
Some studies have revealed that patients with transformed
migraines (more than 15 days/month) are more sensitive to pain than patients
with episodic migraines. This may explain why some of these patients seem
to have less responsiveness to the usual migraine medications( sumatriptan for
example). One study was presented by Dr. Kitsaj at the American Academy
of Neurology Annual Meeting in 2004 . More studies are needed to better
understand this phenomenon and its implications in headache management
CNS News
Zomig (Zolmitriptan) Nasal Spray Demonstrates Rapid Onset of
Migraine Relief
Zolmitriptan (Zomig) study showed a faster response of a nasal spray
preparation compared to placebo. Although the study used 2 hour as a
therapeutic efficacy time window, the nasal spray was also found to be more
efficacious at 15 minutes, 30 minutes and 1 hour compared to placebo.
ACHE
Chronic daily headaches are more common in obese individuals
Dr. Lipton's group has studied the impact of body mass index ( obesity)
on chronic daily headaches frequency, severity and disability. The
prevalence of chronic daily headaches was found to be higher among obese
individuals than normal weight individuals. More obese groups have
the highest prevalence. One more reason to control your weight!.
Ref: See full story in AAN 57the Annual Meeting
supplement to neurology Volume 64, Number 6, supplemt1 S59.00
| 
